Biktarvy, formally known as bictegravir sulfate, represents a effective single-tablet therapy for controlling HIV infection. This medication integrates three crucial antiviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide. It works by inhibiting the HIV's ability to multiply within the body, remarkably lowering the viral quantity.